Talk:Cell adhesion molecule
From Wikipedia, the free encyclopedia
 |
This article is within the scope of the Molecular and Cellular Biology WikiProject. To participate, visit the WikiProject for more information. The WikiProject's current monthly collaboration is focused on improving Restriction enzyme. |
||
| Stub | This article has been rated as Stub-Class on the assessment scale. |
||
| High | This article is on a subject of High-importance within molecular and cellular biology. | ||
|
Article Grading: The article has been rated for quality and/or importance but has no comments yet. If appropriate, please review the article and then leave comments here to identify the strengths and weaknesses of the article and what work it will need. |
|||
[edit] Merger
Proposed incorporation of soluble cell adhesion molecules into this article, perhaps under a heading of Diseases Associated With CAM's; this would also incorporate the current "Neurological Diseases Associated With CAM's" section. If no-one seriously objects, I'll merge the article within a week or two, although with some rewording. --Liveste 05:45, 11 May 2007 (UTC)
- Because of the atherosclerosis connections, current research, potential continued advance in biomarkers and remedial therapies, an additional expandable, more specific article space seems desirable. So I do object.--TheNautilus 13:53, 22 July 2007 (UTC)
- My primary objection to the articles in their current state is that they both have similar titles. However, if "soluble cell adhesion molecules" is the predominant term for the biomarker in atherosclerosis research and treatment (I haven't heard of this term being used in biochemistry), then I will have no further objection to the two articles remaining separate. If this is the case, then I might clean-up the soluble cell adhesion molecules article a bit, to further distinguish the two. Cheers. – Liveste 12:53, 25 July 2007 (UTC)
- I've partly cleaned up the intro to Soluble cell adhesion molecules, which was a bit technical and lacking in context. There's a deal of scope for expansion on the biomarker role - for instance, a very big literature in relation to cardiovascular risk [1], so the term looks well mainstream in this context.
- But be very wary of it turning into a coatrack that's more about orthomolecular therapy than soluble cell adhesion molecules; I notice out of the huge literature on them - see Google Scholar - it's already homing in on papers about fish oil and vitamin C. Gordonofcartoon 02:17, 21 September 2007 (UTC)
- My primary objection to the articles in their current state is that they both have similar titles. However, if "soluble cell adhesion molecules" is the predominant term for the biomarker in atherosclerosis research and treatment (I haven't heard of this term being used in biochemistry), then I will have no further objection to the two articles remaining separate. If this is the case, then I might clean-up the soluble cell adhesion molecules article a bit, to further distinguish the two. Cheers. – Liveste 12:53, 25 July 2007 (UTC)
[edit] ICAM
I think ICAM means intercellular cell adhesion molecule and not intracellular cell adhesion molecule. Could someone with a bit more relevant knowledge confirm or refute this! (a qucik Google search produced more results for intercellular...) Kalambaki2 22:02, 20 August 2007 (UTC) Never mind, I fixed it! (as I realised I was correct after pressing on ICAM-1. Kalambaki2 22:05, 20 August 2007 (UTC)
